March 27, 2013

You are subscribed to the Optometry Times eNews.

Optometry Times News Flash

Web Version  |  Digital Edition  |  Share with a colleague   |   Digital Subscribe  |   Print Subscribe

Facebook Like   Twitter Tweet

TODAY'S HEADLINES

B+L files initial share offering

Bausch + Lomb filed a registration statement with the U.S. Securities and Exchange Commission regarding an initial public offering of its common stock. » More

UK report calls for standardized collection of quality optical data

New report calls for more efficient collection of patient data, says the College of Optometrists in London. » More

Reichert, First Insight create bi-directional integration to track patient readings

Reichert and First Insight partner to offer integration with MaximEyes EHR and Auto Phoroptor RS Refraction System.
» More

TVC launches resource for low vision patients and caregivers

New Web site from The Vision Council aims to educate consumers about low vision. » More

Super Systems announces FastCoat launch

FastCoat from SuperSystems allows independent eyecare practitioners to add polycarbonate lenses to their offerings. » More

Optos receives 510k clearance for microperimetry

The U.S. Food and Drug Administration has granted Optos 510k clearance for microperimetry as part of the company's OptosOCT SLO, allowing for structural OCT and functional microperimetry testing within one instrument. » More

Pulse of the Profession

A bill has been introduced in California to expand the scope of practice to allow ODs and other health professionals to treat systemic diseases such as diabetes and hypertension. Do you feel this is a natural extension of optometric services?


Yes. Optometrists can care for patients with these
   conditions.

Yes, but optometrists need additional training to do so.

No, this is outside optometric education and training.

Vote now!

 

CONNECT WITH Optometry Times

Join your colleagues in conversation, respond to hot-topic questions, and stay up to date on breaking news. Like and follow us today!

Facebook

» Facebook

Facebook

» Twitter

Powered by Modern Medicine Advanstar Medical Communications Group